206 related articles for article (PubMed ID: 35806364)
21. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
22. The Na/K-ATPase α1/Src interaction regulates metabolic reserve and Western diet intolerance.
Kutz LC; Cui X; Xie JX; Mukherji ST; Terrell KC; Huang M; Wang X; Wang J; Martin AJ; Pessoa MT; Cai L; Zhu H; Heiny JA; Shapiro JI; Blanco G; Xie Z; Pierre SV
Acta Physiol (Oxf); 2021 Jul; 232(3):e13652. PubMed ID: 33752256
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of cancer-associated gene expression in activated fibroblasts in a mouse model of non-alcoholic steatohepatitis.
Asakawa M; Itoh M; Suganami T; Sakai T; Kanai S; Shirakawa I; Yuan X; Hatayama T; Shimada S; Akiyama Y; Fujiu K; Inagaki Y; Manabe I; Yamaoka S; Yamada T; Tanaka S; Ogawa Y
Sci Rep; 2019 Dec; 9(1):19601. PubMed ID: 31862949
[TBL] [Abstract][Full Text] [Related]
24. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.
Weinmann A; Alt Y; Koch S; Nelles C; Düber C; Lang H; Otto G; Zimmermann T; Marquardt JU; Galle PR; Wörns MA; Schattenberg JM
BMC Cancer; 2015 Apr; 15():210. PubMed ID: 25884354
[TBL] [Abstract][Full Text] [Related]
25. A Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma.
Kumar DP; Santhekadur PK; Seneshaw M; Mirshahi F; Uram-Tuculescu C; Sanyal AJ
Hepatology; 2019 Apr; 69(4):1520-1534. PubMed ID: 30394550
[TBL] [Abstract][Full Text] [Related]
26. Stress Signal Regulation by Na/K-ATPase As a New Approach to Promote Physiological Revascularization in a Mouse Model of Ischemic Retinopathy.
Wang J; Wang X; Gao Y; Lin Z; Chen J; Gigantelli J; Shapiro JI; Xie Z; Pierre SV
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):9. PubMed ID: 33275652
[TBL] [Abstract][Full Text] [Related]
27. Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma.
Zhang D; Liu J; Xie T; Jiang Q; Ding L; Zhu J; Ye Q
Int J Biol Sci; 2020; 16(15):2812-2827. PubMed ID: 33061798
[TBL] [Abstract][Full Text] [Related]
28. Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
Corbit KC; Wilson CG; Lowe D; Tran JL; Vera NB; Clasquin M; Mattis AN; Weiss EJ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393852
[TBL] [Abstract][Full Text] [Related]
29. Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma.
Udoh US; Rajan PK; Nakafuku Y; Finley R; Sanabria JR
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887082
[TBL] [Abstract][Full Text] [Related]
30. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
[TBL] [Abstract][Full Text] [Related]
31. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
[TBL] [Abstract][Full Text] [Related]
32. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
Grohmann M; Wiede F; Dodd GT; Gurzov EN; Ooi GJ; Butt T; Rasmiena AA; Kaur S; Gulati T; Goh PK; Treloar AE; Archer S; Brown WA; Muller M; Watt MJ; Ohara O; McLean CA; Tiganis T
Cell; 2018 Nov; 175(5):1289-1306.e20. PubMed ID: 30454647
[TBL] [Abstract][Full Text] [Related]
33. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
[TBL] [Abstract][Full Text] [Related]
34. Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.
Yang H; Deng Q; Ni T; Liu Y; Lu L; Dai H; Wang H; Yang W
Int J Biol Sci; 2021; 17(15):4207-4222. PubMed ID: 34803493
[No Abstract] [Full Text] [Related]
35. P(URI)fying Novel Drivers of NASH and HCC: A Feedforward Loop of IL17A via White Adipose Tissue.
Weber A; Heikenwalder M
Cancer Cell; 2016 Jul; 30(1):15-17. PubMed ID: 27411585
[TBL] [Abstract][Full Text] [Related]
36. The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Jojima T; Wakamatsu S; Kase M; Iijima T; Maejima Y; Shimomura K; Kogai T; Tomaru T; Usui I; Aso Y
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652578
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.
Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D
Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281
[TBL] [Abstract][Full Text] [Related]
38. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy.
Gnocchi D; Sabbà C; Massimi M; Mazzocca A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835122
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.
Lakhani HV; Sharma D; Dodrill MW; Nawab A; Sharma N; Cottrill CL; Shapiro JI; Sodhi K
Int J Med Sci; 2018; 15(14):1591-1599. PubMed ID: 30588181
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
